Stay updated with breaking news from Co Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Co-Diagnostics, Inc. (NASDAQ:CODX – Get Free Report) was the target of a large drop in short interest in January. As of January 31st, there was short interest totalling 359,600 shares, a drop of 36.9% from the January 15th total of 570,000 shares. Based on an average daily volume of 109,500 shares, the short-interest ratio is […]
Co-Diagnostics, Inc. (NASDAQ:CODX – Get Free Report) saw a large drop in short interest during the month of January. As of January 15th, there was short interest totalling 570,000 shares, a drop of 9.8% from the December 31st total of 632,000 shares. Based on an average daily volume of 109,200 shares, the short-interest ratio is […]
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...
Co-Diagnostics (NASDAQ:CODX – Free Report) had its price target upped by HC Wainwright from $2.00 to $3.00 in a report released on Monday, Benzinga reports. The firm currently has a neutral rating on the stock. HC Wainwright also issued estimates for Co-Diagnostics’ Q4 2023 earnings at ($0.20) EPS, FY2023 earnings at ($0.90) EPS, Q1 2024 […]
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...